• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左主干冠状动脉血运重建患者 10 年主要不良事件和死亡率的发生率及独立相关因素。

Rates and Independent Correlates of 10-Year Major Adverse Events and Mortality in Patients Undergoing Left Main Coronary Arterial Revascularization.

机构信息

Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Division of Biostatics, Center for Medical Research and Information, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

出版信息

Am J Cardiol. 2020 Apr 15;125(8):1148-1153. doi: 10.1016/j.amjcard.2020.01.023. Epub 2020 Jan 29.

DOI:10.1016/j.amjcard.2020.01.023
PMID:32085865
Abstract

Patients who underwent myocardial revascularization for significant left main coronary artery disease (LMCA) are at high risks of ischemic events and death during follow-up. We sought to determine the independent correlates for very long-term outcomes after LMCA revascularization, which would be clinical value for risk stratification in such high-risk patients. The 10-year rates of clinical outcomes and independent correlates of adverse events were evaluated in 2,240 patients with LMCA disease in the MAIN-COMPARE registry, including 1,102 patients who underwent stenting and 1,138 who underwent coronary artery bypass grafting. The primary outcome was the composite of all-cause death, Q-wave myocardial infarction, or stroke. Secondary outcomes were all-cause mortality and target-vessel revascularization (TVR). The 10-year rates of the primary composite outcome, all-cause mortality, and TVR were 24.7%, 22.2%, and 13.6%, respectively. Age >65 years, diabetes, previous heart failure, cerebrovascular disease, peripheral arterial disease, chronic renal failure, atrial fibrillation, ejection fraction <40%, and distal LMCA bifurcation disease were independent correlates of the primary outcome in the overall population. Several clinical and anatomic parameters were also identified as independent correlates of all-cause death and TVR. Interaction analysis showed no heterogeneities of the effects of variables depending on revascularization type. These clinical descriptors can assist clinicians in identifying high-risk patients within the broad range of risk for patients who underwent LMCA revascularization.

摘要

对于存在严重左主干冠状动脉疾病(LMCA)的患者,经心肌血运重建后在随访期间发生缺血事件和死亡的风险较高。我们旨在确定 LMCA 血运重建后非常长期结局的独立相关因素,这对于此类高危患者的风险分层具有临床价值。在 MAIN-COMPARE 注册研究中,评估了 2240 例 LMCA 疾病患者的 10 年临床结局和不良事件的独立相关因素,包括 1102 例行支架置入术和 1138 例行冠状动脉旁路移植术的患者。主要结局是全因死亡、Q 波心肌梗死或卒中的复合终点。次要结局是全因死亡率和靶血管血运重建(TVR)。主要复合结局、全因死亡率和 TVR 的 10 年发生率分别为 24.7%、22.2%和 13.6%。年龄>65 岁、糖尿病、既往心力衰竭、脑血管疾病、外周动脉疾病、慢性肾衰竭、心房颤动、射血分数<40%和 LMCA 远端分叉病变是全人群中主要结局的独立相关因素。一些临床和解剖参数也被确定为全因死亡和 TVR 的独立相关因素。交互分析显示,取决于血运重建类型的变量的影响没有异质性。这些临床特征可帮助临床医生识别接受 LMCA 血运重建的患者中广泛风险范围内的高危患者。

相似文献

1
Rates and Independent Correlates of 10-Year Major Adverse Events and Mortality in Patients Undergoing Left Main Coronary Arterial Revascularization.左主干冠状动脉血运重建患者 10 年主要不良事件和死亡率的发生率及独立相关因素。
Am J Cardiol. 2020 Apr 15;125(8):1148-1153. doi: 10.1016/j.amjcard.2020.01.023. Epub 2020 Jan 29.
2
Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干狭窄患者的比较:系统评价和荟萃分析。
JAMA Cardiol. 2017 Oct 1;2(10):1079-1088. doi: 10.1001/jamacardio.2017.2895.
3
Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.无保护左主干冠状动脉疾病支架置入与冠状动脉旁路移植术的长期结局:ASAN-MAIN(ASAN 医疗中心-左主干血运重建)注册研究中裸金属支架 10 年和药物洗脱支架 5 年的结果。
J Am Coll Cardiol. 2010 Oct 19;56(17):1366-75. doi: 10.1016/j.jacc.2010.03.097.
4
Comparison of Long-Term Outcomes Following Coronary Revascularization in Men-vs-Women with Unprotected Left Main Disease.男性与女性非保护左主干病变患者冠状动脉血运重建后长期结局的比较。
Am J Cardiol. 2021 Aug 15;153:9-19. doi: 10.1016/j.amjcard.2021.05.016. Epub 2021 Jul 4.
5
Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry.无保护左主干冠状动脉疾病患者支架置入与冠状动脉旁路移植术的长期安全性和疗效:来自 MAIN-COMPARE(无保护左主干冠状动脉狭窄血运重建:经皮冠状动脉介入治疗与外科血管重建比较)注册研究的 5 年结果。
J Am Coll Cardiol. 2010 Jul 6;56(2):117-24. doi: 10.1016/j.jacc.2010.04.004. Epub 2010 May 6.
6
10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease.左主干冠状动脉疾病中支架与冠状动脉旁路移植术的 10 年结果比较。
J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2813-2822. doi: 10.1016/j.jacc.2018.09.012. Epub 2018 Sep 24.
7
Long-Term Outcomes After Stent Implantation for Left Main Coronary Artery (from the Multicenter Assessing Optimal Percutaneous Coronary Intervention for Left Main Coronary Artery Stenting Registry).左主干冠状动脉支架植入后的长期预后(来自多中心评估左主干冠状动脉支架置入术最佳经皮冠状动脉介入治疗注册研究)
Am J Cardiol. 2017 Feb 1;119(3):355-364. doi: 10.1016/j.amjcard.2016.10.033. Epub 2016 Oct 31.
8
Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry.药物洗脱支架与冠状动脉旁路移植术治疗开口左主干冠状动脉疾病的长期疗效和安全性比较:MAIN-COMPARE 注册分析。
Catheter Cardiovasc Interv. 2012 Aug 1;80(2):206-12. doi: 10.1002/ccd.23369. Epub 2012 Jan 10.
9
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.经皮冠状动脉介入治疗开口/中段病变与无保护左主干冠状动脉分叉病变的长期临床结局:DELTA 注册研究(左主干冠状动脉疾病药物洗脱支架):一项多中心注册研究,评估经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干的疗效。
JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.
10
Impact of diabetes mellitus on the treatment effect of percutaneous or surgical revascularization for patients with unprotected left main coronary artery disease: a subgroup analysis of the MAIN-COMPARE study.糖尿病对无保护左主干冠状动脉疾病患者经皮或手术血运重建治疗效果的影响:MAIN-COMPARE 研究的亚组分析。
JACC Cardiovasc Interv. 2009 Oct;2(10):956-63. doi: 10.1016/j.jcin.2009.07.010.

引用本文的文献

1
Safety and efficacy of percutaneous coronary intervention versus coronary artery bypass graft in patients with STEMI and unprotected left main stem disease: A systematic review & meta-analysis.ST段抬高型心肌梗死合并无保护左主干病变患者经皮冠状动脉介入治疗与冠状动脉旁路移植术的安全性和有效性:一项系统评价与荟萃分析
Int J Cardiol Heart Vasc. 2022 Apr 25;40:101041. doi: 10.1016/j.ijcha.2022.101041. eCollection 2022 Jun.